• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

多步骤肝癌发生的早期阶段:腺瘤样增生和早期肝细胞癌。

Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma.

作者信息

Sakamoto M, Hirohashi S, Shimosato Y

机构信息

Pathology Division, National Cancer Center Research Institute, Tokyo, Japan.

出版信息

Hum Pathol. 1991 Feb;22(2):172-8. doi: 10.1016/0046-8177(91)90039-r.

DOI:10.1016/0046-8177(91)90039-r
PMID:1848205
Abstract

From a series of 320 heptocellular carcinoma (HCC) cases treated surgically, we selected small nodular lesions that had not destroyed the preexisting liver structure grossly. After excluding metastases and large regenerative nodules, 58 lesions from 41 cases were chosen. All the lesions were hypercellular. Among them, 33 lesions showing histologic features of very well-differentiated HCC (Edmondson grade I), that is, small hepatocytes with little cellular atypia but with structural atypia, such as a thin trabecular structure of acinar formation in some areas, were classified as early HCC (eHCC). In seven eHCCs, areas of overt carcinoma, classified as Edmondson grade II, were found in the background of Edmondson grade I carcinoma. The remaining 25 lesions lacked structural atypia and were classified as adenomatous hyperplasia (AH). Among the AHs, 10 nodules with a very focal abnormal structure were subclassified as atypical adenomatous hyperplasia (AAH). There was a tendency for the size and cellularity of the atypical lesions to increase in order from AH to AAH to eHCC. All nodules larger than 1.5 cm were eHCC. A degree of cellularity more than twice that of a regenerative nodular was suggested to be an indicator of HCC. All small nodular lesions were associated with chronic liver disease. These histologic observations appear to explain the stepwise development of overt HCC from very well-differentiated eHCC, and of eHCC from AH probably through AAH, at least in cases of HCC associated with chronic liver disease.

摘要

在一组320例接受手术治疗的肝细胞癌(HCC)病例中,我们选择了肉眼未破坏原有肝脏结构的小结节性病变。在排除转移瘤和大的再生结节后,从41例患者中选取了58个病变。所有病变均细胞增多。其中,33个病变具有高分化HCC(Edmondson I级)的组织学特征,即小肝细胞,细胞异型性小但有结构异型性,如某些区域有薄的小梁结构或腺泡形成,被归类为早期HCC(eHCC)。在7例eHCC中,在Edmondson I级癌的背景中发现了被归类为Edmondson II级的明显癌灶。其余25个病变缺乏结构异型性,被归类为腺瘤样增生(AH)。在AH中,10个具有非常局灶性异常结构的结节被亚分类为不典型腺瘤样增生(AAH)。非典型病变的大小和细胞数量有从AH到AAH再到eHCC逐渐增加的趋势。所有大于1.5 cm的结节均为eHCC。细胞数量比再生结节多两倍以上被认为是HCC的一个指标。所有小结节性病变均与慢性肝病有关。这些组织学观察结果似乎解释了至少在与慢性肝病相关的HCC病例中,从高分化的eHCC发展为明显HCC的逐步过程,以及从AH可能通过AAH发展为eHCC的过程。

相似文献

1
Early stages of multistep hepatocarcinogenesis: adenomatous hyperplasia and early hepatocellular carcinoma.多步骤肝癌发生的早期阶段:腺瘤样增生和早期肝细胞癌。
Hum Pathol. 1991 Feb;22(2):172-8. doi: 10.1016/0046-8177(91)90039-r.
2
Nucleolar organizer regions in small nodular lesions representing early stages of human hepatocarcinogenesis.代表人类肝癌发生早期阶段的小结节性病变中的核仁组织区。
Cancer. 1994 Jan 15;73(2):289-93. doi: 10.1002/1097-0142(19940115)73:2<289::aid-cncr2820730209>3.0.co;2-g.
3
Frequent occurrence of hepatocellular carcinoma in cirrhotic livers after surgical resection of atypical adenomatous hyperplasia (borderline hepatocellular lesion): a follow-up study.非典型腺瘤样增生(临界性肝细胞病变)手术切除后肝硬化肝脏中肝细胞癌的频繁发生:一项随访研究
Am J Gastroenterol. 1994 Jun;89(6):903-8.
4
A clinicopathologic study of adenomatous hyperplasia of the liver in 209 consecutive cirrhotic livers examined by autopsy.对209例经尸检的连续性肝硬化肝脏中肝腺瘤样增生的临床病理研究。
Cancer. 1993 Sep 1;72(5):1551-6. doi: 10.1002/1097-0142(19930901)72:5<1551::aid-cncr2820720511>3.0.co;2-q.
5
Histopathological and morphometric analysis of atypical adenomatous hyperplasia of human cirrhotic livers.人类肝硬化肝脏非典型腺瘤样增生的组织病理学和形态计量学分析
Virchows Arch A Pathol Anat Histopathol. 1993;422(5):381-8. doi: 10.1007/BF01605457.
6
Early hepatocellular carcinoma with high-grade atypia in small vaguely nodular lesions.小的模糊结节性病变中伴有高级别异型性的早期肝细胞癌。
Cancer Sci. 2016 Apr;107(4):543-50. doi: 10.1111/cas.12893. Epub 2016 Mar 18.
7
Increased ubiquitin immunoreactivity in hepatocellular carcinomas and precancerous lesions of the liver.肝细胞癌及肝脏癌前病变中泛素免疫反应性增强。
J Hepatol. 1997 Jun;26(6):1266-73. doi: 10.1016/s0168-8278(97)80461-8.
8
Adenomatous hyperplasia of the liver as a precancerous lesion.
Liver. 1993 Feb;13(1):1-9. doi: 10.1111/j.1600-0676.1993.tb00597.x.
9
Cell proliferative activity in adenomatous hyperplasia of the liver and small hepatocellular carcinoma. An immunohistochemical study demonstrating proliferating cell nuclear antigen.
Cancer. 1992 Aug 1;70(3):591-8. doi: 10.1002/1097-0142(19920801)70:3<591::aid-cncr2820700309>3.0.co;2-7.
10
Selective necrosis of encapsulated malignant lesion within atypical adenomatous hyperplasia of the liver following transarterial embolization. A report of two autopsy cases.经动脉栓塞后肝脏非典型腺瘤样增生内包被性恶性病变的选择性坏死。两例尸检病例报告。
J Clin Gastroenterol. 1991 Dec;13(6):709-14. doi: 10.1097/00004836-199112000-00020.

引用本文的文献

1
Risk of Malignancy in Indeterminate Liver Nodules Among Patients with Cirrhosis: A Retrospective Cohort Study.肝硬化患者不确定肝脏结节恶性肿瘤风险:一项回顾性队列研究。
J Gastrointest Cancer. 2024 Oct 16;56(1):1. doi: 10.1007/s12029-024-01122-7.
2
MR radiomics to predict microvascular invasion status and biological process in combined hepatocellular carcinoma-cholangiocarcinoma.磁共振成像放射组学预测肝细胞癌-胆管癌合并症中的微血管侵犯状态及生物学过程
Insights Imaging. 2024 Jul 9;15(1):172. doi: 10.1186/s13244-024-01741-5.
3
IDEAL-IQ measurement can distinguish dysplastic nodule from early hepatocellular carcinoma: a case-control study.
IDEAL-IQ测量可区分发育异常结节与早期肝细胞癌:一项病例对照研究。
Quant Imaging Med Surg. 2024 Jun 1;14(6):3901-3913. doi: 10.21037/qims-23-1593. Epub 2024 Apr 22.
4
Circulating miRNA's biomarkers for early detection of hepatocellular carcinoma in Egyptian patients based on machine learning algorithms.基于机器学习算法的循环 miRNA 生物标志物在埃及患者肝细胞癌早期检测中的应用。
Sci Rep. 2024 Feb 29;14(1):4989. doi: 10.1038/s41598-024-54795-2.
5
Liver Lesions at Risk of Transformation into Hepatocellular Carcinoma in Cirrhotic Patients: Hepatobiliary Phase Hypointense Nodules without Arterial Phase Hyperenhancement.肝硬化患者中具有转化为肝细胞癌风险的肝脏病变:肝胆期低强化结节且动脉期无强化。
J Clin Transl Hepatol. 2024 Jan 28;12(1):100-112. doi: 10.14218/JCTH.2023.00130. Epub 2023 Nov 29.
6
Tumor Endothelial Cells-Associated Integrin Alpha-6 as a Promising Biomarker for Early Detection and Prognosis of Hepatocellular Carcinoma.肿瘤内皮细胞相关整合素α-6作为肝细胞癌早期检测和预后的有前景生物标志物
Cancers (Basel). 2023 Aug 17;15(16):4156. doi: 10.3390/cancers15164156.
7
Surveillance, Diagnosis, and Treatment Outcome of Hepatocellular Carcinoma in Japan: 2023 Update.日本肝细胞癌的监测、诊断及治疗结果:2023年更新
Liver Cancer. 2023 Mar 9;12(2):95-102. doi: 10.1159/000530079. eCollection 2023 Jun.
8
HIF 1 α - a promising target for the treatment of meningiomas.缺氧诱导因子1α——治疗脑膜瘤的一个有前景的靶点。
Med Pharm Rep. 2023 Apr;96(2):170-174. doi: 10.15386/mpr-2059. Epub 2023 Apr 27.
9
Diagnostic and therapeutic roles of iron oxide nanoparticles in biomedicine.氧化铁纳米颗粒在生物医学中的诊断和治疗作用。
Tzu Chi Med J. 2022 Jul 27;35(1):11-17. doi: 10.4103/tcmj.tcmj_65_22. eCollection 2023 Jan-Mar.
10
Prognostic stratification based on mC regulators acts as a novel biomarker for immunotherapy in hepatocellular carcinoma.基于 mC 调节剂的预后分层可作为肝细胞癌免疫治疗的新型生物标志物。
Front Immunol. 2022 Sep 9;13:951529. doi: 10.3389/fimmu.2022.951529. eCollection 2022.